Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
about
Profile of blonanserin for the treatment of schizophreniaThe effects of neuroleptics on the GABA-induced Cl- current in rat dorsal root ganglion neurons: differences between some neurolepticsBlonanserin - A Novel Antianxiety and Antidepressant Drug? An Experimental Study.Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone.Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.
P2860
Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Pharmacological profile of AD- ...... onin-S2 antagonist properties.
@ast
Pharmacological profile of AD- ...... onin-S2 antagonist properties.
@en
Pharmacological profile of AD- ...... onin-S2 antagonist properties.
@nl
type
label
Pharmacological profile of AD- ...... onin-S2 antagonist properties.
@ast
Pharmacological profile of AD- ...... onin-S2 antagonist properties.
@en
Pharmacological profile of AD- ...... onin-S2 antagonist properties.
@nl
prefLabel
Pharmacological profile of AD- ...... onin-S2 antagonist properties.
@ast
Pharmacological profile of AD- ...... onin-S2 antagonist properties.
@en
Pharmacological profile of AD- ...... onin-S2 antagonist properties.
@nl
P2093
P1476
Pharmacological profile of AD- ...... tonin-S2 antagonist properties
@en
P2093
Furukawa K
Karasawa T
Kurumiya S
P304
P407
P577
1993-01-01T00:00:00Z